-
Daily-life Sensor Based Measurement of Tremor Presence and Amplitude
-
Dandy-Walker syndrome. A case study.
-
Data-driven image-based subtyping and staging of neurodegeneration in Parkinson’s disease
-
Deciphering the Role of Auranofin-Loaded Nanoparticles Against Rotenone Model of Parkinson’s Disease: Via GSK-3β/ Nrf2/HO-1 Signaling Pathways
-
Decline in functionality according to WHODAS 2.0 associated with disease progression in people with Parkinson’s disease
-
Declining Lymphocyte Count and Lymphocyte-to-Neutrophil Ratio Following Parkinson’s Disease Diagnosis.
-
Decoding Fatigue in Parkinson’s Disease: Exploring Multifactorial Associations
-
Decoding non-IPD Parkinsonism – A Comparative Analysis of Atypical and Secondary Parkinsonism
-
Decrease in Walking Ability with Increased Functional Connectivity between Multiple Brain Areas in Parkinson’s Disease
-
Deep Brain Stimulation (DBS) Improves Parkinsonism Caused by Osmotic Demyelination Syndrome (ODS)
-
Deep Brain Stimulation Complications in Parkinson’s Disease Patients: A 15-year Single-Centre Review
-
Deep brain stimulation contact selection using Neurophysiology and Artificial intelligence
-
Deep Brain Stimulation during pregnancy: A systematic review of the literature
-
Deep Brain Stimulation for Post-Hypoxic Myoclonus: A Case Correlating Local Field Potentials to Clinical Outcome
-
Deep Brain Stimulation for Primary Refractory Tinnitus: A Systematic Review
-
Deep brain stimulation for severe dystonia associated with Wilson’s disease: A prospective multicentre meta-analysis of Nof1 trials
-
Deep Brain Stimulation From the Perspective of Relatives and Caregivers: A Qualitative Analysis and Caregiver Burden
-
Deep Brain Stimulation in Dystonia: Investigating Differential Response by Dystonia Distribution
-
Deep Brain Stimulation in Tourette Syndrome: Characteristics of Three Patients Pre and Post Implantation
-
Deep brain stimulation Intraoperative imaging: False errors in the era of artificial intelligence
-
Deep Brain Stimulation of bilateral ventral intermediate nucleus in a patient with spinocerebellar ataxia type 12
-
Deep brain stimulation of bilateral ventral intermediate nucleus in patients with neuronal intranuclear inclusion disease
-
Deep brain stimulation of globus pallidus internus for monogenic dystonia
-
Deep Brain Stimulation of the Subthalamic Nuclei in Advanced Parkinson’s Disease what Effects on Motor Non-motor and Neuropsychological Functions a Monocentric Prospective Study with a 12-month Follow-up
-
Deep Brain Stimulation Surgery – Hurdles and Maladies!
-
Deep brain stimulation-evoked potentials as an avenue to optimize stimulation outcomes in Parkinson’s disease
-
Deep Brain Stimulators in Parkinson`s subthalamic nucleus: A Study of Decade Follow-Up
-
Deep learning-based Prediction of Gait Dysfunction in Parkinson’s Disease using Quantitative Diffusion MRI from Brain Network Regions of Interest
-
Deep learning-based Prediction of Visual Dysfunction in Parkinson’s Disease from 31 Brain Regions of Interest using Quantitative Diffusion MRI
-
Delayed movement disorders after usage of desomorphine-“crocodile”. Clinical case.
-
Delayed Parkinsonism as a Delayed Neurological Sequele in Carbon Monoxide Intoxication: A Rare Case Report
-
Delineating the Molecular and Clinical Spectrum of Epilepsy-Dyskinesia Syndromes in Children (The Epilepsy-Dyskinesia Spectrum Study)
-
Demographics of Botulinum toxin therapy population representative to demographics in Essex County, USA
-
Dentate Deep Brain Stimulation for Cerebellar Ataxia: Long Term Outcomes
-
Dentato-Rubro-Thalamic Tract Deep Brain Stimualtion for Essential Tremor: Stimulation Parameters and Clinical Outcomes
-
Deposition of phosphorylated TDP-43 around the tip of deep brain stimulation leads
-
Depression and Cognitive Phenotype in Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Results of a Comparative Study of a New Scale ESDEPARK Assessing Depressive Symptomatology Specifically in IPDWD vs a General Geriatric Depression Scale.
-
Depressive Symptomatology and Neuropsychiatric Profile in Patients with Idiopathic Parkinson’s Disease without Dementia (IPDWD). Preliminary Data from a New Scale Specifically for Measuring Depression in Patients with IPDWD.
-
Dermal 4R-Tau seeding as a novel biomarker for Progressive Supranuclear Palsy
-
Design, synthesis and pharmacological evaluation of 16-pyridylmethylene derivatives of steroidal oximes as antiparkinsonian agents in MPTP-injected mice.
-
Designing a Device for Real-time Monitoring and Digital Integration of Non-motor Symptoms
-
Detecting impulsivity through speech in patients with Parkinson’s Disease: A principle proof study
-
Detecting Mild Cognitive Impairment in Parkinson’s Disease using Speech Markers
-
Determinants of nocturnal arterial hypertension in Parkinson’s disease patients in Cameroon
-
Determining and Leveraging Local Ancestry to Assess Individual-Level Risk: from the Global Parkinson’s Genetics Program
-
Determining Cerebrospinal Fluid Alpha-Synuclein Seed Amplification Assay Status from Demographics and Clinical Data
-
Determining the Direction of segmented DBS Micro Electrodes through the EEG
-
Determining the optimal filtering method for the removal of gait-related movement artefacts from EEG acquired from People with Parkinson’s Disease
-
Developing a selection framework for digital measures of Parkinson’s disease progression for the EJS ACT-PD trial
-
Developing a Supervised Machine Learning Model for Long-Term Cognitive Status Prediction in Parkinson Disease
-
Developing a Supportive Care and Wellness Program for Parkinson’s Patients
-
Developing a Virtual Brick-Building Group for Veterans with Movement Disorders
-
Developing Composite Digital Measures for Tracking Parkinson’s Disease (PD) Progression using a Comprehensive Machine Learning-based Framework
-
Developing composite measures that track physical activity change in people with early-stage Parkinson’s disease using machine learning and wearable sensors
-
Development and Feasibility Trial of iSupport-PD, a Digital intervention for carers of people with Parkinson’s and Cognitive Impairment
-
Development and Validation of a Clinical Scale for Distinguishing Multiple System Atrophy from 4-Repeat Tauopathies
-
Development of a Beta-sensing Pathway in Deep brain stimulation to optimise utility of Local field potential recordings using the Percept system. (Newcastle Beta-sensing Algorithm – NBA)
-
Development of a National Initiative for the Professionalization of Parkinson Nurses – Results from Germany
-
Development of an AAV-mediated artificial miRNA targeting human alpha-synuclein (α-syn) as a potential gene therapy for Synucleinopathies
-
Device-aided Recording of Gait Parameters and Motor Fluctuations in Patients with advanced Parkinson’s disease in the Home Environment
-
Diabetic striatopathy with stroke – like symptoms: A case report
-
Diagnosing Young-Onset and Familial Parkinson’s Disease Using an Extensive Targeted Panel
-
Diagnostic Challenges in Functional Neurological Disorder: Convergent Psychogenic Non-Epileptic Seizures and Psychosis
-
Diagnostic challenges with novel SCA variants: A case of STUB1 mutation
-
Diagnostic Spectrum in a Cohort of Atypical Atypical Parkinsonism
-
Differences in Molecular and Ultrastructural profiles of astroglia and microglia in substantia nigra of two different mice strains in normal aging and experimental Parkinsonism
-
Differences in Oculometric Measures between Patients with LRRK2-associated and Idiopathic Parkinson’s Disease
-
Differences in regional activity levels between healthy controls, PD-nFOG, and PD-FOG as measured by ALFF and fALFF using resting-state fMRI.
-
Differential Diagnosis of Parkinsonism with 18F-FP-CIT PET using a Self-supervised Deep Learning Model
-
Differential Symptom Cluster Responses and Predictors to Repetitive Transcranial Magnetic Stimulation Treatment in Parkinson’s Disease:A Retrospective Study
-
Differentiating Progressive Supranuclear Palsy from Corticobasal Syndrome Using Cortical Diffusion MRI
-
Differentiating the Local Field Potential Oscillations in Low and Beta Range in Parkinson`s and Dystonic Movement Disorder
-
Diffusion MRI and Machine Learning Distinguish Alzheimer’s Disease and Dementia with Lewy Bodies
-
Digital health technology (DHT) derived features as sensitive measures of disease progression in early Parkinson’s disease under stable dopaminergic treatment
-
Discriminating alpha-synuclein strains in Parkinson’s disease
-
Disease Burden and Treatment in Patients With Essential Tremor in the United States: Real-World Evidence From a Cross-Sectional Survey of Physicians and Patients
-
Disease Progression in Patients with PLA2G6-related Parkinsonism: A Longitudinal Study
-
Disease-related comprehensive motor pattern derived from 2D single RGB video as a biomarker for early and prodromal Parkinson disease
-
Disparities in Botulinum Toxin Utilization for Cervical Dystonia in a United States Medicare Population
-
Disrupted Sleep Circadian Rhythms and Brain Disorders: A Large Prospective Cohort Study
-
Dissecting Neural Circuits Regulating Sleep State Transitions in a Mouse Model of Parkinson’s Disease
-
Distinct Gut Microbiome in Parkinson’s disease Based on the Presence of Premotor Rapid-Eye Movement Sleep Behavior Disorders: Exploring the Alpha-synuclein
-
Distinct pattern of synaptic loss in Parkinson’s disease depression and initial findings from the Yale Ketamine PD (KET-PD) trial
-
Distinct patterns of Gene Expression in Skin-biopsy Derived Fibroblasts of Patients with Parkinson’s disease
-
Distinguishing Parkinson’s disease from atypical Parkinsonian syndrome using multistage deep learning based on dopamine transporter imaging
-
Distress Tolerance in Patients with Tremor Disorders
-
Do differences in risk aversion and perceived social support contribute to gender disparities in deep brain stimulation utilization in Parkinson’s disease
-
Do Lower Doses of Botulinum Neurotoxin Type-A Offer a Longer Duration of Effect and Superior Efficacy in Patients with Cervical Dystonia?
-
Do Proton Pump Inhibitors Increase the Risk of Parkinson’s Disease? A systematic review and meta-analysis
-
Does cannabis increase one’s risk for a fall in Parkinson’s disease?: cross-sectional analysis of self-report balance problems and freezing of gait
-
Dopa-responsive ataxia with compound heterozygous variants in MRE11
-
Dopamine agonist use and psychotic symptoms in patients with Parkinson’s disease.
-
Dopamine Dysregulation in Parkinson’s Disease and Substance Use: Therapeutic Use and Compulsive Behaviors Thin Line
-
Dopamine Dysregulation Syndrome Outcomes following Pallidal Deep Brain Stimulation in Parkinson’s Disease
-
Dopamine Transporter Imaging as Monitoring Biomarker in Parkinson’s Disease
-
Dopamine transporter imaging to predict the risk of aspiration in patients with Parkinson’s disease
-
Dopaminergic Adverse Events With 24-hour Subcutaneous Infusion of ND0612
-
Dopaminergic alterations in patients with Alzheimer’s disease
-
Dopaminergic denervation and focal motor progression in early Parkinson’s Disease: A 5-year longitudinal study
-
Dose-dependent alterations of lysosomal activity and alpha-synuclein level in peripheral blood monocyte-derived macrophages and SH-SY5Y neuroblastoma cell line by upon inhibition of mTOR kinase activity
-
DPPX Autoimmune Encephalitis Associated with Severe Multifocal Dystonia.
-
Driving assessment in older patients with Parkinson’s in United Kingdom.
-
Drug-Induced Parkinsonism and Tardive Dyskinesia in Rats Chronically Treated with Haloperidol
-
Drug-induced tremors: A scoping review to assess knowledge gaps, controversies, and future directions
-
Dual Frequency Stimulation of the Subthalamic Nucleus Improves Emotional State in Parkinson’s Disease
-
Dual Pathways of Holmes Tremor Suggested from the Experience of Deep Brain Stimulation
-
Dual-Task Cost of Walking While Using a Smartphone: A Comparison Study of Older Adults with and Without Cognitive Decline
-
Dynamic video-assessment of axial postural abnormalities in parkinsonism: feasibility and pilot analysis
-
Dysfluent Writing Behavior Associates with Reduced Striatal-cerebellar Connectivity in Writer’s Cramp Dystonia
-
Dysphagia is Frequent in early Parkinson´s Disease. Results from a 5-year Follow-up Study.
-
Dysregulated Anti-Viral Response in LRRK2 Mice Following Infection with H1N1 Influenza Induces DA Neuron Loss in the SNpc.
-
Dystonia and Impact on Employment in a Spanish Cohort
-
DystoniaDBSNet: A novel deep learning biomarker of predictive treatment outcomes in dystonia
-
DYT-KMT2B generalized dystonia managed with GPi-DBS
2024 International Congress
September 27-October 1, 2024. Philadelphia, PA.